Approval · Notice of Compliance 18084 · 2016
DOM-VALACYCLOVIR: Notice of Compliance 18084
Issued May 9, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18084
- Date
- May 9, 2016
- Company
- Dominion PharmacalMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product monograph update to match the innovator's product monograph
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOM-VALACYCLOVIR | 02307936 | Cancelled Post Market |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per TAB